Search details
1.
Cost-effectiveness of poly-(ADP-ribose) polymerase (PARP)-inhibitors for the maintenance treatment after responding to first- and second-line chemotherapy in advanced ovarian cancer.
J Oncol Pharm Pract
; 29(2): 457-464, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36344039
2.
Cost-effectiveness of pembrolizumab in first-line for microsatellite-instability-high or mismatch-repair-deficient metastatic colorectal cancerF.
J Oncol Pharm Pract
; 29(4): 958-961, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-36823960
3.
The cost-effectiveness of new first-line therapies approved in advanced hepatocellular carcinoma.
J Oncol Pharm Pract
; 28(2): 434-437, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-34581219
4.
Cost-effectiveness of encorafenib plus cetuximab in BRAF V600E-mutated colorectal cancer.
J Oncol Pharm Pract
; 28(1): 199-202, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34581610
5.
The cost-effectiveness of atezolizumab in first-line for metastatic triple negative breast cancer is heavily linked to PD-L1 level.
J Oncol Pharm Pract
; 27(5): 1245-1247, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-34018861
6.
Stereotactic body radiotherapy for oligometastatic castration sensitive prostate cancer using 1.5 T MRI-Linac: preliminary data on feasibility and acute patient-reported outcomes.
Radiol Med
; 126(7): 989-997, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33835309
7.
Cost-effectiveness of maintenance therapy after first-line treatment in metastatic colorectal cancer.
J Oncol Pharm Pract
; 28(1): 194-198, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34558365
8.
Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.
Radiat Oncol
; 15(1): 178, 2020 Jul 22.
Article
in English
| MEDLINE | ID: mdl-32698843
9.
Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study.
Biomedicines
; 8(12)2020 Dec 14.
Article
in English
| MEDLINE | ID: mdl-33327494
10.
Cost-Effectiveness of the New Combination Trifluridine/Tipiracil Plus Bevacizumab for the Third-Line Treatment for Metastatic Colorectal Cancer in Italy.
Clin Colorectal Cancer
; 23(1): 1-3, 2024 03.
Article
in English
| MEDLINE | ID: mdl-37932152
11.
The screening with the liquid biopsy for the rechallenge with anti-epidermal growth factor receptor antibodies in metastatic colorectal cancer A perspective based on pharmacological costs.
Recenti Prog Med
; 114(9): 563-564, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37530025
12.
Long-term survivors of metastatic colorectal cancer treated with trifluridine/tipiracil.
Recenti Prog Med
; 113(6): 380-382, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35758117
13.
Cost-effectiveness of programmed death ligand-1 (PD-L1) blockade in first-line for metastatic gastric/gastroesophageal junction cancer.
Eur J Cancer
; 175: 193-195, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36137394
14.
Whey proteins isolate supplementation in additional to nutritional counseling in cancer patients.
Recenti Prog Med
; 113(6): 383-384, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35758118
15.
Covid-19 patients with cancer: what do they risk? Clinical, radiological and therapeutic features.
Recenti Prog Med
; 112(6): 476-481, 2021 06.
Article
in English
| MEDLINE | ID: mdl-34128942
16.
The optimal duration of immune checkpoint inhibitors in non-oncogene addicted non-small cell lung cancer: less is more? An open question.
Recenti Prog Med
; 112(12): 802-804, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34924575
17.
Computerization during the antineoplastic compounding process guarantees greater adherence to evidence-based medicine for the prophylaxis of chemotherapy-induced nausea and vomiting.
Recenti Prog Med
; 112(6): 470-471, 2021 06.
Article
in English
| MEDLINE | ID: mdl-34128940
Results
1 -
17
de 17
1
Next >
>>